Besides, SMARCA4 was a promising prognostic marker for the disease‐free interval (DFI) in melanoma patients (Figure S2 E) and was significantly elevated in melanoma patients, compared with normal skin tissues (Figure 2H). Here, SMARCA4 is linked to melanoma.